AMD Follows NVIDIA's H20 Lead, Confirms MI308 Chip Export Resumption to China

Deep News
07-16

Shortly after NVIDIA secured U.S. government approval to resume H20 chip sales in China, Advanced Micro Devices confirmed it will restart exporting its MI308 chips to the Chinese market. AMD indicated its export license applications have entered the review phase, with approvals anticipated.

The development trails NVIDIA's earlier announcement about recommencing H20 chip sales in China. AMD disclosed that the U.S. Commerce Department recently notified the company that its MI308 license applications would proceed, stating it "plans to resume shipments upon approval." In an official statement, AMD praised the Trump administration's progress in trade negotiations and commitment to U.S. artificial intelligence leadership.

Both semiconductor giants previously faced AI hardware export constraints under consecutive administrations. The Biden administration enacted comprehensive AI proliferation regulations, while the subsequent Trump administration revoked those rules but imposed specific restrictions on H20 and MI308 chips. AMD estimated these measures would cause approximately $800 million in losses across inventory, procurement commitments, and reserves—significantly less than NVIDIA's $5.5 billion write-down yet impactful enough to strain AMD's finances. This policy reversal consequently delivers positive momentum for AMD.

Following the announcement, AMD shares surged nearly 5% in pre-market trading, paralleling NVIDIA's gains. The lifting of export bans on H20 and MI308 chips signifies a substantial policy shift in Washington. NVIDIA CEO Jensen Huang has consistently opposed such restrictions, criticizing export controls as ineffective while applauding the revocation of AI proliferation rules. Huang repeatedly cautioned that such measures could diminish U.S. influence in global AI development and accelerate domestic innovation in countries like China, potentially catalyzing competing hardware solutions.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10